Updated April 2026 · SEC DEF 14A data
Pharmaceuticals, CEO Pay Comparison
CEOs in the Pharmaceuticals sector earn an average of $32.1M per year (median $32.1M) across 2 tracked public companies with a real SEC-disclosed CEO total compensation figure.
2 companies tracked · sector rank #9 of 22 for average compensation
Pharmaceuticals covers 2 U.S. public companies in our SEC proxy-statement dataset. Average CEO compensation in the industry runs $32.1M, with a median of $32.1M — the spread between mean and median is wide because a handful of mega-cap firms pull the average well above the median. The highest-paid CEO in Pharmaceuticals is at Eli Lilly, with SEC-disclosed total compensation of $36.7M. Every figure here is the disclosed Summary Compensation Table "Total" from each company’s DEF 14A proxy statement.
Industry-level CEO pay analysis is most useful for peer-group comparisons. Compensation committees explicitly select peer groups when setting CEO pay, so cross-industry comparisons need to control for the peer-group structure that drives the underlying decisions.
What Pharmaceuticals Pay Looks Like
$32.1M places this industry at the top of the U.S. CEO compensation distribution — rank 9 of 22 sectors tracked here. At this level, equity awards typically dominate the package, and a single mega-grant of restricted stock or performance share units routinely accounts for two-thirds or more of the headline number.
Highest Paid CEOs in Pharmaceuticals
How Pharmaceuticals Stacks Up Against Other Sectors
Across the 22 sectors tracked by CEOPayWatch, Pharmaceuticals ranks #9 in average CEO compensation. Sector-level averages are computed from the same SEC-disclosed Summary Compensation Table "Total" figures used on individual company profiles, so the rank reflects where this industry's average disclosed package sits in the live distribution. The cross-sector average compensation is $36.6M, which puts Pharmaceuticals $4.5M below the typical industry baseline.
The dispersion within an industry frequently matters more than the cross-sector ranking. A sector can have a high average compensation driven by two or three mega-pay outliers while the median company is paid modestly. The companies listed above show the top of the pay distribution for Pharmaceuticals; the full company list further down shows the broader distribution. Both lists link to individual company profiles where the source DEF 14A on SEC EDGAR is one click away.
All Pharmaceuticals Companies
How These Sector Numbers Are Calculated
The Pharmaceuticals average and median on this page are simple unweighted statistics across the 2 companies CEOPayWatch tracks in the sector that carry a real SEC-disclosed CEO total. Average and median compensation come from each company's most recent reported total comp in its DEF 14A Summary Compensation Table (the disclosed "Total" line, iXBRL ecd:PeoTotalCompAmt). We report the disclosed totals only and never estimate them. Authoritative governance context for shareholder votes comes from Institutional Shareholder Services (ISS) and Glass Lewis frameworks.
Frequently Asked Questions
How much do Pharmaceuticals CEOs earn?
Average SEC-disclosed CEO total compensation in Pharmaceuticals is $32.1M, with a median of $32.1M across 2 tracked public companies. $32.1M places this industry at the top of the U.S. CEO compensation distribution — rank 9 of 22 sectors tracked here. At this level, equity awards typically dominate the package, and a single mega-grant of restricted stock or performance share units routinely accounts for two-thirds or more of the headline number.
Where does the Pharmaceuticals pay data come from?
Every figure on this page is the SEC-disclosed headline total compensation (iXBRL ecd:PeoTotalCompAmt — the Summary Compensation Table "Total" line) from each company's DEF 14A proxy statement filed with the U.S. Securities and Exchange Commission. The filings are available on SEC EDGAR at https://www.sec.gov/edgar.shtml. We report the disclosed totals only and never estimate them.
How does Pharmaceuticals compare to other sectors?
Among the 22 sectors CEOPayWatch tracks, Pharmaceuticals ranks #9 in average CEO compensation. Compensation in the sector runs $4.5M below the cross-sector average of $36.6M.
Related Industries
Source: U.S. Securities and Exchange Commission, DEF 14A proxy filings via EDGAR. Public domain.
Last updated 2026-04-06 · 2 companies in the Pharmaceuticals sector.